A newly discovered potential biomarker may aid in the diagnosis and treatment of sporadic amyotrophic lateral sclerosis (ALS), according to a research letter published in the Journal of Neurology, Neurosurgery, and Psychiatry.
A newly discovered potential biomarker may aid in the diagnosis and treatment of sporadic amyotrophic lateral sclerosis (ALS), according to a research letter published in the Journal of Neurology, Neurosurgery, and Psychiatry.
A newly discovered potential...